ARTICLE | Clinical News
Ergo preclinical data
January 15, 1996 8:00 AM UTC
Carefully timed administration of bromocriptine in animals produced a significant reduction in nocturnal lipolysis and hepatic glucose production, according to a study published in Metabolism.
These effects were accompanied by a 75 percent decrease in circulating insulin while improving diurnal (daytime) glucose tolerance. ...